Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction
- aHoward Hughes Medical Institute and
- bDepartment of Physiology, University of California, San Francisco, CA 94158;
- cDepartment of Neuroscience, High Throughput Biology Center, School of Medicine, Johns Hopkins University, Baltimore, MD 21205;
- dLung Biology Center, Department of Medicine, University of California, San Francisco, CA 94158;
- eDepartment of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Kanazawa, Yokohama 236-0004, Japan;
- fDivision of Pulmonary and Critical Care Medicine, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, CA 94143;
- Departments of gAnatomy,
- jPathology, and
- hMedicine, School of Medicine, University of California, San Francisco, CA 94143; and
- iDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710
See allHide authors and affiliations
Contributed by Lily Yeh Jan, August 23, 2012 (sent for review June 1, 2012)

Abstract
Mucous cell hyperplasia and airway smooth muscle (ASM) hyperresponsiveness are hallmark features of inflammatory airway diseases, including asthma. Here, we show that the recently identified calcium-activated chloride channel (CaCC) TMEM16A is expressed in the adult airway surface epithelium and ASM. The epithelial expression is increased in asthmatics, particularly in secretory cells. Based on this and the proposed functions of CaCC, we hypothesized that TMEM16A inhibitors would negatively regulate both epithelial mucin secretion and ASM contraction. We used a high-throughput screen to identify small-molecule blockers of TMEM16A-CaCC channels. We show that inhibition of TMEM16A-CaCC significantly impairs mucus secretion in primary human airway surface epithelial cells. Furthermore, inhibition of TMEM16A-CaCC significantly reduces mouse and human ASM contraction in response to cholinergic agonists. TMEM16A-CaCC blockers, including those identified here, may positively impact multiple causes of asthma symptoms.
Footnotes
- ↵1To whom correspondence may be addressed. E-mail: jason.rock{at}ucsf.edu or lily.jan{at}ucsf.edu.
Author contributions: F.H., H.Z., M.W., H.Y., M.K., C.J.P., P.G.W., O.D.S., X.H., D.S., J.V.F., W.F., M.L., Y.-N.J., L.Y.J., and J.R.R. designed research; F.H., H.Z., M.W., H.Y., M.K., C.J.P., P.G.W., O.D.S., M.L.D., X.H., J.V.F., M.L., Y.-N.J., L.Y.J., and J.R.R. performed research; F.H., H.Z., M.W., H.Y., P.G.W., O.D.S., X.H., J.V.F., P.J.W., B.L.M.H., W.F., M.L., Y.-N.J., L.Y.J., and J.R.R. contributed new reagents/analytic tools; F.H., H.Z., M.W., H.Y., M.K., C.J.P., P.G.W., O.D.S., M.L.D., X.H., D.S., J.V.F., M.L., Y.-N.J., L.Y.J., and J.R.R. analyzed data; and F.H., C.J.P., Y.-N.J., L.Y.J., and J.R.R. wrote the paper.
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1214596109/-/DCSupplemental.